Ｈｅａｒｔｓｅｅｄ株式会社
Tokyo, Japan
Active| Registration number | T4011001108455 |
|---|---|
| Type | Corporation |
| Registered name | Ｈｅａｒｔｓｅｅｄ株式会社 |
| Address | 東京都港区芝浦１丁目２番３号 1-2-3 Shibaura, Minato-ku, Tokyo 105-0023, JAPAN |
| Corporate number | 4011001108455 |
| Corporate number assigned on | 2015-12-14 |
| Invoice registered on | 2023-10-01 |
| Record last updated | 2024-01-30 |
The invoice registration date is when the qualified-invoice-issuer registration (T-number) took effect — it is not the date the company was founded, and it resets only if the business re-registers after revocation or expiry.
Corporate registry record
| Entity type | Kabushiki Kaisha (stock company) |
|---|---|
| Representative | 代表取締役社長 福田 惠一 |
| Reading (furigana) | ハートシード |
| Reading (romaji) | Hatoshido |
| English name (unofficial) | Heartseed K.K. |
| Postal code | 105-0023 |
Source: NTA Corporate Number Publication Site, refreshed daily. Representative: gBizINFO (METI, monthly).
Company profile (gBizINFO)
| Employees | 43 |
|---|---|
| Capital | ¥1.33B |
Source: gBizINFO (METI), refreshed monthly — edited extract by LoreaTec. Figures are as filed by each company.
Timeline — registry changes
| 2023-09-05 | Head-office address changed (Japan) |
|---|
Source: daily change files of the NTA Corporate Number Publication Site. Before 2023-08-16 only the latest change is known. All company events →
Government contract awards (GEPS)
No public national-government (GEPS) award records for this company in the open data (FY2013 to date).
出典：調達ポータル（https://www.p-portal.go.jp/）
Payments from national budget programmes (行政事業レビュー)
Ministry review sheets report this company as a payee of 1 programme (2 lines, sheet years 2024–2025; total ¥104.0M).
| 2025 FY2024 | 医療・健康推進事業（うち再生医療・遺伝子治療の産業化に向けた基盤技術開発事業） ¥52.0M （経済産業省） 民間企業を中心とした実用化において、プロジェクトの実施を担う機関 |
|---|---|
| 2024 FY2023 | 医療・健康推進事業（うち再生医療・遺伝子治療の産業化に向けた基盤技術開発事業） ¥52.0M （経済産業省） 補助金等交付先 |
Contract details (excerpt): 再生・細胞医療・遺伝子治療産業化促進事業（自家iPS細胞由来再生心室筋細胞移植による難治性重症心不全治療法の開発） ¥52.0M・補助金等交付 · bidders 22 ／ 再生・細胞医療・遺伝子治療産業化促進事業（自家iPS細胞由来再生心室筋細胞移植による難治性重症心不全治療法の開発） ¥52.0M・補助金等交付 · bidders 22
Source: 行政事業レビュー見える化サイト (Cabinet Secretariat, PDL 1.0) — edited extract by LoreaTec. A sheet year describes the previous fiscal year’s spending. Programme database →
Verify in official sources
Doing due diligence on this supplier?
Verifying the invoice number is step one. Our guide covers the full checklist: corporate registry, licenses, and import/export standing.
How to cite this page
Data via LoreaTec BizSearch (https://bizsearch.loreatec.jp/t4011001108455) — Source: National Tax Agency corporate-number and qualified-invoice registries. Retrieved 2026-09-21.
Reusing this page, or answering with it? Paste this line. Training and AI answers are allowed — attribution is the only condition. AI content licence